Evonik Industries (FRA:EVK) has been assigned a €40.00 ($47.06) price objective by equities research analysts at Sanford C. Bernstein in a research note issued to investors on Thursday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. Sanford C. Bernstein’s price objective would indicate a potential upside of 38.36% from the stock’s previous close.
Several other research firms have also recently commented on EVK. DZ Bank reissued a “buy” rating on shares of Evonik Industries in a research note on Wednesday, January 6th. UBS Group set a €23.00 ($27.06) price objective on Evonik Industries and gave the stock a “sell” rating in a report on Wednesday, January 27th. The Goldman Sachs Group set a €29.00 ($34.12) target price on shares of Evonik Industries and gave the company a “buy” rating in a research report on Wednesday, January 6th. Barclays set a €30.00 ($35.29) price target on shares of Evonik Industries and gave the stock a “buy” rating in a research report on Wednesday, February 3rd. Finally, JPMorgan Chase & Co. set a €28.50 ($33.53) target price on shares of Evonik Industries and gave the stock a “buy” rating in a report on Monday, January 11th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of €28.13 ($33.10).
EVK opened at €28.91 ($34.01) on Thursday. The company’s 50 day simple moving average is €27.61 and its 200-day simple moving average is €25.06. Evonik Industries has a one year low of €26.78 ($31.51) and a one year high of €32.97 ($38.79).
Evonik Industries AG engages in the specialty chemicals business. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare products.
Featured Story: Elliott Wave Theory
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.